ORIGINAL RESEARCH
Accepted on 09 Oct 2025
Phase 2 Trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma
doi 10.3389/fimmu.2025.1672790
522
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.